Clinical Trial Phases

LEARN ABOUT OUR CLINICAL TRIAL PHASES AND HOW YOU CAN PARTICIPATE

Every new treatment undergoes thorough extensive testing to ensure both its safety and effectiveness.
Clinical trials progress through multiple phases, each designed to evaluate specific aspects of a potential therapy from early safety assessments to large-scale studies measuring efficacy and outcomes. At Phase 1 Research, we are dedicated to advancing medical innovations while placing the safety and well-being of our participants at the forefront of every study.

PHASE I

Phase I trials are the first stage of testing an investigational drug, focusing on evaluating its safety and identifying possible side effects in a small group of healthy volunteers.

PHASE 1b

A Phase 1b trial is an early-stage study that builds on the safety data from a Phase 1a trial. Its main objectives are to further evaluate safety, determine the optimal dosing regimen, and gather initial evidence of efficacy in a selected group of patients with the target condition.

PHASE II

Phase II trials build on initial safety data to further assess potential risks and determine the most effective dosage, typically involving a larger group of participants than Phase I.

PHASE 2b

A Phase 2b trial is a mid-stage study designed to assess both the efficacy and safety of a new treatment in a larger group of patients with the target condition. This phase focuses on identifying the optimal dose, evaluating therapeutic benefits, and further characterizing the safety profile to support later-stage clinical development.

PHASE III

Phase III trials study the safety and effectiveness of an investigational drug in a larger population of patients with the targeted condition. These trials often compare the new drug to current treatments or a placebo to validate earlier findings. Successful results are submitted to regulatory authorities, such as the FDA or EMA, for approval.

PHASE IV

Phase IV trials occur after a drug has received regulatory approval and is available to the public. They monitor long-term safety, effectiveness, and explore additional uses in a broader patient population.

What Our Partners & Participants Say

Real experiences, real impact—discover how New Med Research is making a difference in clinical research.

Even the all-powerful Pointing has no control about the blind texts it is an almost unorthographic life One day however a small line of blind text by the name of Lorem Ipsum decided to leave for the far World of Grammar. The Big Oxmox advised her